Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Aldosteronism In Hypertensive Patients in China

NCT03155139 is registered in ClinicalTrials.gov with Qifu Li as lead sponsor.

NCT NCT03155139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03155139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Aldosteronism In Hypertensive Patients in China
Lead sponsor
Qifu Li
Phase
Observational
Overall status
Completed
Start date
June 3, 2017
Completion date
November 30, 2018
Enrollment
3,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperaldosteronism; primary, hypertension secondary